Correlation of Loss of CD4 T Cells with Plasma Levels of Both Soluble Form Fas (CD95) and Fas Ligand (FasL) in HIV-Infected Infants

By Hosaka N.   Oyaizu N.   Than S.   Pahwa S.  

Clinical Immunology, Vol. 95, Iss. 1, 2000-04 ,pp. : 20-25

Academic Press

Access to resources Recommend Favorite

The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment‐naïve, asymptomatic HIV‐infected individuals

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 4, 2015-08 ,pp. : 450-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy

By Savès M.   Morlat P.   Chêne G.   Peuchant E.   Pellegrin I.   Bonnet F.   Bernard N.   Lacoste D.   Salamon R.   Beylot J.  

Clinical Immunology, Vol. 99, Iss. 3, 2001-06 ,pp. : 347-352

Academic Press

Access to resources Recommend Favorite

Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral Therapy

By Schmidt Barbara   Fujimura Sue   Martin Jeffrey   Levy Jay  

Journal of Clinical Immunology, Vol. 26, Iss. 1, 2006-01 ,pp. : 55-64

Springer Publishing Company

Access to resources Recommend Favorite

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).

By  

Current Molecular Medicine, Vol. 15, Iss. 10, 2015-12 ,pp. : 975-979

Bentham Science Publishers

Access to resources Recommend Favorite